Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020981514> ?p ?o ?g. }
Showing items 1 to 98 of
98
with 100 items per page.
- W2020981514 endingPage "213" @default.
- W2020981514 startingPage "207" @default.
- W2020981514 abstract "Irinotecan (CPT-11) has shown considerable activity in colorectal cancer, and its combination with 5-fluorouracil (5-FU) represents an attractive approach. A phase I study was conducted to determine the maximum tolerated dose (MTD) and the dose-limiting toxicities (DLTs) of CPT-11 in combination with a continuous infusion of 5-FU for 4 days.Forty-two patients with histologically confirmed metastatic colorectal cancer who had not received prior treatment for advanced disease were enrolled. The patients' median age was 64 years; 26 (62%) patients were men, and the performance status (WHO) was 0 in 26 (62%) patients, 1 in 15 (36%) and 2 in 1 (2%). Twenty-two (52%) patients had 2 or more metastatic sites. CPT-11 (starting dose 200 mg/m(2)) was administered as a 30-min intravenous infusion with increments of 50 mg/m(2) on day 4. 5-FU (starting dose 400 mg/m(2)) was administered as a 4-day continuous intravenous infusion with increments of 50 mg/m(2) on days 1-4. Treatment was repeated every 4 weeks.The MTD of the combination was found to be 600 mg/m(2) for 5-FU and 350 mg/m(2) for CPT-11. Neutropenia, febrile neutropenia and delayed diarrhea were the DLTs. Grade 3/4 neutropenia was observed in 22 (13%) out of 169 administered treatment cycles, febrile neutropenia in 7 (4%) and grade 3/4 diarrhea in 20 (12%). Other toxicities were mild. Among 36 patients evaluable for response, partial response was achieved in 8 (22%), stable disease in 12 (33%) and progressive disease in 16 (44%) patients. Responses were mostly seen at the higher dose levels.The combination of a 4-day continuous infusion of 5-FU followed by CPT-11 represents an active and well-tolerated regimen for patients with colorectal cancer. This regimen merits further evaluation in phase II studies." @default.
- W2020981514 created "2016-06-24" @default.
- W2020981514 creator A5014224438 @default.
- W2020981514 creator A5025351482 @default.
- W2020981514 creator A5026478600 @default.
- W2020981514 creator A5027807165 @default.
- W2020981514 creator A5035832029 @default.
- W2020981514 creator A5046050577 @default.
- W2020981514 creator A5055771176 @default.
- W2020981514 creator A5059774082 @default.
- W2020981514 creator A5077848597 @default.
- W2020981514 creator A5078192662 @default.
- W2020981514 creator A5023034870 @default.
- W2020981514 date "2001-01-01" @default.
- W2020981514 modified "2023-09-27" @default.
- W2020981514 title "A Dose-Finding Study of Irinotecan (CPT-11) plus a Four-Day Continuous 5-Fluorouracil Infusion in Advanced Colorectal Cancer" @default.
- W2020981514 cites W118757060 @default.
- W2020981514 cites W1832060645 @default.
- W2020981514 cites W1952371628 @default.
- W2020981514 cites W1962270700 @default.
- W2020981514 cites W2003872607 @default.
- W2020981514 cites W2010991676 @default.
- W2020981514 cites W2021009641 @default.
- W2020981514 cites W2048648630 @default.
- W2020981514 cites W2057409012 @default.
- W2020981514 cites W2096122707 @default.
- W2020981514 cites W2128447158 @default.
- W2020981514 cites W2149505692 @default.
- W2020981514 cites W2227311140 @default.
- W2020981514 cites W2602544133 @default.
- W2020981514 doi "https://doi.org/10.1159/000055320" @default.
- W2020981514 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11340371" @default.
- W2020981514 hasPublicationYear "2001" @default.
- W2020981514 type Work @default.
- W2020981514 sameAs 2020981514 @default.
- W2020981514 citedByCount "3" @default.
- W2020981514 countsByYear W20209815142017 @default.
- W2020981514 countsByYear W20209815142019 @default.
- W2020981514 crossrefType "journal-article" @default.
- W2020981514 hasAuthorship W2020981514A5014224438 @default.
- W2020981514 hasAuthorship W2020981514A5023034870 @default.
- W2020981514 hasAuthorship W2020981514A5025351482 @default.
- W2020981514 hasAuthorship W2020981514A5026478600 @default.
- W2020981514 hasAuthorship W2020981514A5027807165 @default.
- W2020981514 hasAuthorship W2020981514A5035832029 @default.
- W2020981514 hasAuthorship W2020981514A5046050577 @default.
- W2020981514 hasAuthorship W2020981514A5055771176 @default.
- W2020981514 hasAuthorship W2020981514A5059774082 @default.
- W2020981514 hasAuthorship W2020981514A5077848597 @default.
- W2020981514 hasAuthorship W2020981514A5078192662 @default.
- W2020981514 hasConcept C121608353 @default.
- W2020981514 hasConcept C126322002 @default.
- W2020981514 hasConcept C141071460 @default.
- W2020981514 hasConcept C2776694085 @default.
- W2020981514 hasConcept C2776907518 @default.
- W2020981514 hasConcept C2777063308 @default.
- W2020981514 hasConcept C2778850193 @default.
- W2020981514 hasConcept C2779802037 @default.
- W2020981514 hasConcept C2780259306 @default.
- W2020981514 hasConcept C2780456651 @default.
- W2020981514 hasConcept C526805850 @default.
- W2020981514 hasConcept C71924100 @default.
- W2020981514 hasConcept C90924648 @default.
- W2020981514 hasConceptScore W2020981514C121608353 @default.
- W2020981514 hasConceptScore W2020981514C126322002 @default.
- W2020981514 hasConceptScore W2020981514C141071460 @default.
- W2020981514 hasConceptScore W2020981514C2776694085 @default.
- W2020981514 hasConceptScore W2020981514C2776907518 @default.
- W2020981514 hasConceptScore W2020981514C2777063308 @default.
- W2020981514 hasConceptScore W2020981514C2778850193 @default.
- W2020981514 hasConceptScore W2020981514C2779802037 @default.
- W2020981514 hasConceptScore W2020981514C2780259306 @default.
- W2020981514 hasConceptScore W2020981514C2780456651 @default.
- W2020981514 hasConceptScore W2020981514C526805850 @default.
- W2020981514 hasConceptScore W2020981514C71924100 @default.
- W2020981514 hasConceptScore W2020981514C90924648 @default.
- W2020981514 hasIssue "3" @default.
- W2020981514 hasLocation W20209815141 @default.
- W2020981514 hasLocation W20209815142 @default.
- W2020981514 hasOpenAccess W2020981514 @default.
- W2020981514 hasPrimaryLocation W20209815141 @default.
- W2020981514 hasRelatedWork W1821252775 @default.
- W2020981514 hasRelatedWork W2001682523 @default.
- W2020981514 hasRelatedWork W2068688816 @default.
- W2020981514 hasRelatedWork W2075311499 @default.
- W2020981514 hasRelatedWork W2113805173 @default.
- W2020981514 hasRelatedWork W2122694119 @default.
- W2020981514 hasRelatedWork W2135412015 @default.
- W2020981514 hasRelatedWork W2155636605 @default.
- W2020981514 hasRelatedWork W2169946736 @default.
- W2020981514 hasRelatedWork W2339706385 @default.
- W2020981514 hasVolume "60" @default.
- W2020981514 isParatext "false" @default.
- W2020981514 isRetracted "false" @default.
- W2020981514 magId "2020981514" @default.
- W2020981514 workType "article" @default.